Byline: Melissa Rohman
-
Neural Stem Cell Therapy May Improve Metastatic Cancer Survival
Neural stem cells engineered by Northwestern Medicine investigators used in combination with the HER2 inhibitor drug tucatinib improved survival in mice with HER2 positive breast cancer brain metastases.
-
Remembering Jeremiah Stamler, MD, Founding Chair and Professor Emeritus of Preventive Medicine
Jeremiah Stamler, MD, founding chair and professor emeritus of Preventive Medicine, passed away on January 26. He was 102 years old.
-
Medical Student Investigates Pre-Pregnancy Cardiovascular Health
Michael Wang, a fourth-year medical student, is the lead author of a study recently selected by the American Heart Association as one of the top heart disease and stroke research advances of 2021.
-
Balancing Act: The Science of Inflammation
Feinberg scientists including the lab of William Muller, MD, PhD, are investigating how regulating inflammation can be a pathway to treating a range of diseases.
-
Uncovering Cellular Mechanisms of Genetic Skin Diseases
Northwestern Medicine investigators have discovered a novel mechanism linking an intercellular adhesion molecule with genetic inflammatory skin diseases.
-
Medical School Introduces Digital Health and Data Science Curriculum
The medical school has begun introducing a new component of the medical education curriculum: instruction in Digital Health and Data Science for medical students.
-
Miller Named Distinguished Fellow of American Association of Immunologists
Stephen Miller, PhD, the Judy Gugenheim Research Professor of Microbiology-Immunology, has been named an American Association of Immunologists’ 2022 Distinguished Fellow.
-
Study Finds Marijuana Use Increasing Among Pregnant Individuals with HIV
Marijuana use among pregnant and postpartum individuals living with HIV increased from 2007 to 2019, according to a Northwestern Medicine study.
-
Genomic Variant May Predict Cardiotoxicity From Chemotherapy
A team of investigators have discovered a novel genomic variant that may help clinicians predict which patients will experience cardiotoxicity from a widely used chemotherapy drug, according to a Northwestern Medicine study.
-
Study Reveals Potential Therapeutic Target for Genetic Liver Disease
Northwestern Medicine investigators have discovered the molecular mechanisms underlying a rare genetic disorder that increases the risk of severe liver disease, according to a recent study.
